相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiogenic Factors in Superimposed Preeclampsia A Longitudinal Study of Women With Chronic Hypertension During Pregnancy
Uma Perni et al.
HYPERTENSION (2012)
Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial
Valerie A. Holmes et al.
DIABETES CARE (2011)
Angiogenic Factors and Preeclampsia
Sharon E. Maynard et al.
SEMINARS IN NEPHROLOGY (2011)
Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial
David R. McCance et al.
LANCET (2010)
Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies
Robert W. Powers et al.
PLOS ONE (2010)
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
Mark A. Hlatky et al.
CIRCULATION (2009)
Obstetric and Perinatal Outcomes in Type 1 Diabetic Pregnancies A large, population-based study
Martina Persson et al.
DIABETES CARE (2009)
Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women
Y. Yu et al.
DIABETOLOGIA (2009)
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia
Juan Pedro Kusanovic et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2009)
The Global Impact of Pre-eclampsia and Eclampsia
Lelia Duley
SEMINARS IN PERINATOLOGY (2009)
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
Roberto Romero et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Circulating levels of the antiangiogenic marker soluble FM-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia - Angiogenic markers in preeclampsia and preexisting diabetes
Allison Cohen et al.
DIABETES CARE (2007)
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
Richard J. Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Outcomes in type 1 diabetic pregnancies - A nationwide, population-based study
DM Jensen et al.
DIABETES CARE (2004)
Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop
GC McKeeman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia
SE Maynard et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy
RW Gifford et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
分享论文
